A research team from the Department of Surgery and the Department of Medicine, School of Clinical Medicine, LKS Faculty of ...
Risk factors are things that raise your chances of getting a disease. For each person, there’s a mix of genetic, biological and lifestyle factors that play a part in prostate cancer risk. About 1 in ...
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Because most of the major risk factors are beyond your control, there’s no proven way to truly reduce ...
November 18, 2008 (Washington, DC) — The use of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) is significantly associated with lower levels of prostate-specific antigen (PSA).
Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on disease progression. Among patients with intermediate-risk prostate cancer, ...
Former US President Joe Biden has been diagnosed with prostate cancer, according to a statement from his office on Sunday. Mr Biden sought medical attention last week due to urinary symptoms, and a ...
About 1 in 8 men will learn they have prostate cancer at some point in their lifetime. And while most of those who are diagnosed will survive, prostate cancer can be serious. It's the second-leading ...
A study from HKUMed demonstrates that prostate-specific antigen (PSA) screening can significantly reduce the incidence of ...
Prostate-cancer screening based on prostate-specific antigen (PSA) levels in the blood was introduced—and readily adopted—in the United States around the late 1980s. But this screening method, in ...
This article was reviewed by Darragh O’Carroll, MD. PSA and Testosterone: Are They Linked? Prostate-specific antigen (PSA) is a term you’ll probably become familiar with once you start getting ...
After skin cancer, prostate cancer is the most commonly diagnosed cancer among men in the United States. In fact, one in eight men will be diagnosed with prostate cancer during their lifetime, ...